Recovery measures and treatment methods
| Variable | AMAN | AIDP | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Treatment (No of patients) | Treatment (No of patients) | ||||||||
| IVIG (n = 13) | PP (n = 21) | None (n = 10) | Total (n = 44) | IVIG (n = 11) | PP (n = 14) | None (n = 8) | Total (n = 33) | ||
| AIDP, acute inflammatory demyelinating polyneuropathy; AMAN, acute motor axonal neuropathy; IVIG, intravenous immunoglobulin; PP, plasmapheresis. | |||||||||
| Improvement by two or more Hughes grades during the first four weeks | 4 (9%) | 8 (18%) | 0 (0%) | 12 (27%) | 4 (12%) | 2 (6%) | 0 (0%) | 6 (18%) | |
| Hughes grade 3 or more six months after onset | 2 (5%) | 4 (9%) | 0 (0%) | 6 (14%) | 2 (6%) | 0 (0%) | 0 (0%) | 2 (6%) | |